FloridaMarijuana.net
JUNE 22, 2018
A 2004 study demonstrated that cannabinoids “decrease motor activity in the stomach and decrease gastric emptying,” which eases the uncomfortable and painful abdominal cramping; significantly decreasing bathroom visits after a meal. A second option available for treating pain is the Sativa-dominant hybrid Harlequin.
Cannabis Law Report
JANUARY 23, 2020
852/2004 of the European Parliament and of. Council of 29 April 2004 on the hygiene of food products; Having regard to Regulation (EC) no. 853/2004 of the European Parliament and of. Council of 29 April 2004 laying down specific rules in. 854/2004 of the European Parliament and of the. of Cannabis sativa L.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Project CBD
JULY 12, 2023
A study in the African Journal of Traditional, Alternative and Complementary Medicine mentions an effective traditional treatment for tuberculosis using cannabis leaf macerated in warm water, as administered by Bapedi healers of Limpopo province, South Africa. Cannabis roots. The Journal of Phytopharmacology. 2014 3(1): 35-43. Callaway, J.
Greencamp
FEBRUARY 17, 2019
One study from 2004 looked at cannabinoids as a treatment option for managing bowel diseases symptoms (including IBS), because of their anti-inflammatory properties, but also the ability to diminish pain levels. Cannabis (more precisely its compound CBD), is a proven anti-inflammatory agent. (
The Cannigma
JANUARY 13, 2023
4 A 2004 study found that the endocannabinoid anandamide can inhibit trigeminal neurons, which suggests a way in which endocannabinoids may be able to prevent migraines. Daily cannabis consumption was an effective treatment for 85% of participants. 5 THC and migraines THC is well-known for its anti-nausea and pain-relieving effects.
Greencamp
AUGUST 16, 2018
Even though these effects were observed on mice, all mammals have neurological and cellular similarities, and the team in charge of this study concluded that: “With respect to the treatment of ALS, from both a disease modifying and symptom management viewpoint, clinical trials with cannabis are the next logical step.
Cannabis Law Report
OCTOBER 29, 2019
Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs. Dogs received each of two treatments: CBD oil (2 mg/kg) or placebo oil every 12 h. Each treatment lasted for 4 weeks with a 2-week washout period. Veterinary assessment showed decreased pain during CBD treatment ( p < 0.02).
Expert insights. Personalized for you.
189 
Let's personalize your content